Physician profile
Robert Michael Cobb
NPI 1447359047
$6,597.85
in general payments reported to CMS, 2019-2025
21 companies · $1,230 in 2025
The $1,230 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,795 · 2020: $275 · 2021: $356 · 2022: $282 · 2023: $402 · 2024: $2,259 · 2025: $1,230.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,225 · Food and Beverage: $1,665.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,225.15 |
| Food and Beverage | $1,665.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $4,274.78 | 2019-2025 | Journey II, Legion Revision, Ri Hip Navigation |
| Zimmer Biomet Holdings, INC. | $1,009.88 | 2025 | Oxford |
| Ferring Pharmaceuticals INC. | $174.73 | 2019-2024 | Euflexxa |
| Pacira Therapeutics, INC. | $164.89 | 2020-2021 | |
| Onkos Surgical, INC. | $160.72 | 2021 | |
| Amgen INC. | $151.81 | 2019-2024 | Evenity, Prolia |
| Djo, LLC | $99.07 | 2024-2025 | Cmf |
| Orthofix Medical, INC. | $73.48 | 2019-2025 | Physio-Stim |
| Depuy Synthes Sales INC. | $68.43 | 2019-2023 | Orthovisc, Monovisc |
| Pacira Pharmaceuticals Incorporated | $68.22 | 2019-2024 | Zilretta, Iovera, Exparel |
| Boston Scientific Corporation | $65.73 | 2022-2023 | Wavewriter Alpha Prime 16 |
| Cumberland Pharmaceuticals, INC. | $62.74 | 2020 | |
| Stryker Corporation | $41.00 | 2024-2025 | System 9 Cd Nxt |
| Bioventus LLC | $36.82 | 2021 | |
| Heraeus Medical, LLC. | $34.38 | 2020-2022 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Heron Therapeutics, INC. | $23.21 | 2022 | |
| Convatec INC. | $21.61 | 2020 | |
| Fidia Pharma USA INC. | $18.75 | 2021 | |
| Acelrx Pharmaceuticals, INC. | $18.09 | 2021 | |
| Sanofi-Aventis U.S. LLC | $16.48 | 2020 | |
| Gentleman Orthopedic Solutions | $13.03 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Cobb listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.